CABALETTA BIO, INC. Operating Lease Liability
CABALETTA BIO, INC. (CABA) had Operating Lease Liability of $953.00 thousand as of 2023-10-01, per its 10-Q filed 2024-11-14.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2024-11-14
- 2023-10-01: Operating Lease, Liability $953.00K; Operating Lease, Liability as first filed $953.00.
- 2023-09-30: Operating Lease, Liability $0.00.
- 2022-12-31: Operating Lease, Liability $1.53M.
- 2021-12-31: Operating Lease, Liability $0.00.
| Period end | Operating Lease, Liability | Operating Lease, Liability as first filed |
|---|---|---|
| 2023-10-01 | $953.00K 10-Q · filed 2024-11-14 | $953.00 10-K · filed 2024-03-21 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-09 | |
| 2022-12-31 | $1.53M 10-K · filed 2023-03-16 | |
| 2021-12-31 | $0.00 10-K · filed 2023-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |